Share on StockTwits
 

Trevena (NASDAQ:TRVN) major shareholder Laboratories Holdings L. Forest acquired 428,571 shares of the company’s stock in a transaction dated Wednesday, February 5th. The stock was purchased at an average price of $7.00 per share, with a total value of $2,999,997.00. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Large shareholders that own at least 10% of a company’s stock are required to disclose their sales and purchases with the SEC.

Shares of Trevena (NASDAQ:TRVN) traded up 1.60% during mid-day trading on Friday, hitting $7.00. The stock had a trading volume of 50,996 shares. Trevena has a 52-week low of $6.00 and a 52-week high of $7.25. The stock has a 50-day moving average of $6.3 and a 200-day moving average of $6.3. The company’s market cap is $5.8 million.

Trevena, Inc (NASDAQ:TRVN) is a clinical stage biopharmaceutical company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.